Cellosaurus HEp2-Mx2/EGFP L1G5 (CVCL_RX05)
Cell line name | HEp2-Mx2/EGFP L1G5 |
---|---|
Synonyms | HEp L1G5; L1G5 |
Accession | CVCL_RX05 |
Resource Identification Initiative | To cite this cell line use: HEp2-Mx2/EGFP L1G5 (RRID:CVCL_RX05) |
Comments | Problematic cell line: Contaminated. Parent cell line (HEp-2) has been shown to be a HeLa derivative. Population: African American. Biotechnology: Used for a reporter gene assay (RGA) of the human type 1 interferon potency (PubMed=27346232). Characteristics: Expression of eGFP is under the control of the control of the mouse Mx2 promoter (PubMed=27346232). Genetic integration: Method=Transfection/transduction; Gene=FPbase; R9NL8; eGFP (Note=Enhanced GFP). Genetic integration: Method=Transfection/transduction; Gene=UniProtKB; P00552; Transposon Tn5 neo. Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18). Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002. |
Disease | Human papillomavirus-related cervical adenocarcinoma (NCIt: C27677) |
Species of origin | Homo sapiens (Human) (NCBI Taxonomy: 9606) |
Hierarchy | Parent: CVCL_1906 (HEp-2) |
Sex of cell | Female |
Age at sampling | 30Y6M |
Category | Cancer cell line |
Publications | PubMed=22373148; DOI=10.1186/1753-6561-5-S8-P4; PMCID=PMC3284889 PubMed=27346232; DOI=10.1016/j.jbiotec.2016.06.021 |
Cross-references | |
Encyclopedic resources | Wikidata; Q54882751 |
Entry history | |
Entry creation | 05-Mar-2018 |
Last entry update | 10-Sep-2024 |
Version number | 8 |